Business Wire

ACAMS 14th Annual AML & Financial Crime Conference - Europe

Del

Regulatory changes and technological disruption are currently reshaping European Anti-Financial Crime initiatives. ACAMS’ 14th Annual European AML & Financial Crime Conference brings together industry leading experts to offer insight on the new skills, tools and strategies that will help compliance professionals successfully navigate this era of rapid change. The conference, centered on the theme “Mastering the New Era of European Compliance” will take place at the RAI Amsterdam, Netherlands from May 31 – June 1, 2018. The conference includes a keynote presentation by Alexandra Jour-Schroeder, director for criminal justice at the European Commission, on 5AMLD and its practical implications for compliance professionals.

“The role of the AML professional is quickly evolving from one of sub-area specialists to those with a broader knowledge base and diverse skills,” said Rick McDonell, executive director of ACAMS and former executive secretary for the Financial Action Task Force. “Accelerating the evolution of AML compliance practices and professionals will require greater dialogue between the private sector, enforcement bodies and regulators – something ACAMS is well-positioned to facilitate.”

The Europe conference provides in-depth training, regulatory updates and critical solutions to regional AML compliance challenges. It is the largest dedicated AML conference in the region, and represents a unique opportunity for the AML/CTF/anti-financial crime community to meet. Plenary sessions will address topics as 4AMLD & GDPR, Sanctions, the Terrorism Threat in Europe and Cybercrime. Specialist ‘AML Knowledge’ and ‘AML Innovations’ tracks will spotlight the latest breakthroughs in sector technology.

“The pace of change in European anti-financial crime policy and practice continues unabated, and topics like artificial intelligence, cybercrime, AML data analytics and how to combat terror financing and human trafficking have never been more important,” said Angela Salter, head of Europe at ACAMS. “This conference brings together current and future leaders of our industry to learn from one another and to connect with their peers across both private and public sectors. We’re proud to be the catalyst for this sharing of cutting-edge best practice and anti-financial crime professional development.”

Led by industry leaders in banking, government and law enforcement, the Europe Conference’s panels and workshops tackle critical AML issues head-on, with thought-provoking sessions, such as:

  • Cybercrime: Can it Ever be Prevented?
    • Analyze recent cybercrime cases to highlight the current cyber threat landscape
    • Create models for common cyber-typologies and red flags indicating potential cybercrime activities
    • Create a cyber-event response plan to investigate damage, restore systemic integrity and notify stakeholders including law enforcement and regulators
  • Compliance with Converging Regulation: A Holistic Approach Towards the Implementation of 4AMLD/ GDPR & PSD2
    • Raise awareness of regulatory impact assessments as a tool for more effective regulatory change planning
  • Making the Invisible More Visible: Tackling Bribery and Corruption
    • Examine recent FCPA prosecutions of European entities and lessons learned from them
    • Review approaches taken by other financial institutions to identify the behavior of customer involved in bribery and corruption
  • The Ever-Changing Specter of Sanctions Risks
    • Evaluate the impact of the current evolving global political landscape in Venezuela, Russia, Cuba, Myanmar and others, and sanction screening activities
    • Learn about new and emerging evasion techniques used sanctions targets to gain access to the global financial system

Speakers include:

  • Remy Jansen, Head of Department De Nederlandsche Bank, Netherlands
  • Erik Barnett, Europe Regional Head of Financial Crime Threat Mitigation, HSBC
  • Sharon Campbell, Global Head of Financial Crime Compliance, Nordea
  • Geraldine Lawlor, Global Head of Financial Crime, Barclays
  • Philippe Vollot, Managing Director, Global Head of AFC & Group Anti-Money Laundering Officer, Deutsche Bank
  • Eric Strom, Cyber Specialist, FBI, Netherlands
  • Andy McDonald, former Head of UK National Terrorist Financial Investigation Unit, New Scotland Yard, United Kingdom

For more information and to download a full conference schedule, visit http://www.acamsconferences.org/europe.

Editor’s Note: Members of the media may contact Ernie Gibble (ernie.gibble@adtalem.com) at +1 630.353.9920 for credentials to cover the conference.

About the Association of Certified Anti-Money Laundering Specialists ® (ACAMS ® )

ACAMS is a member of Adtalem Global Education (NYSE: ATGE), a global education provider headquartered in the United States. ACAMS is the largest international membership organization dedicated to enhancing the knowledge and skills of anti-money laundering (AML) and financial crime professionals from a wide range of industries, with extensive resources designed to develop and sharpen the skills required for superior job performance and career advancement. Its CAMS certification is the most widely recognized AML certification among compliance professionals worldwide. Visit acams.org for more information.

About Adtalem Global Education

The purpose of Adtalem Global Education is to empower students to achieve their goals, find success and make inspiring contributions to our global community. Adtalem Global Education Inc. (NYSE: ATGE; member S&P MidCap 400 Index) is a leading global education provider, and the parent organization of Adtalem Educacional do Brasil, American University of the Caribbean School of Medicine, Association of Certified Anti-Money Laundering Specialists, Becker Professional Education, Carrington College, Chamberlain University, DeVry University and its Keller Graduate School of Management, Ross University School of Medicine and Ross University School of Veterinary Medicine. For more information, please visit adtalem.com.

Contact information

Media Contact for Conference Attendance:
Adtalem Global Education
Ernie Gibble
o: +1.630.353.9920
m: +1.773.454.7132
ernie.gibble@adtalem.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00Pressemelding

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07Pressemelding

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 07:58Pressemelding

Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs